Cesarean-derived, colostrum-deprived pigs (n ϭ 23) were inoculated intranasally and subcutaneously with a low cell culture passage of type 2 porcine circovirus. In 11 pigs, a persistent fever that lasted 7-17 days began 12-15 days after inoculation with virus. Additional signs of disease in those 11 pigs included depression (11 of 11 pigs), palpable enlargement of inguinal, prefemoral, and popliteal lymph nodes (11 of 11), icterus (6 of 11), and hyperpnea (2 of 11). The remaining 12 pigs had fever that occurred intermittently for 2-4 days between days 12 and 20 postinoculation. Overt signs of disease in those pigs were limited to palpable enlargement of inguinal and popliteal lymph nodes (9 of 12 pigs). When compared with control pigs of similar age, the average daily rate of weight gain for all pigs inoculated with virus was less over a 2-week period that began 2 weeks post inoculation. At postmortem examination, lymph node enlargement was seen in 14 of 14 pigs euthanized between days 20 and 28 postinoculation. Lymph node enlargement was especially prominent in pigs that developed a persistent fever. Microscopic lesions noted in pigs that developed a persistent fever included cellular depletion in lymphoid tissues; hepatic cell necrosis; and lymphogranulomatous inflammation of lymph nodes, Peyer's patches of the intestine, liver, kidney, and heart. Virus was isolated with varying frequency from nasal, rectal, or tonsil swab specimens, buffy coat, serum, urine, and lung lavage fluid obtained antemortem or postmortem. Virus was isolated from or viral DNA was detected in a variety of tissues obtained postmortem up to 125 days postinoculation. Antibody against type 2 porcine circovirus usually was detected in serum between 15 and 20 days postinoculation; however, antibody against virus was not detected in serum from 4 pigs euthanized 20-24 days postinoculation. Direct contact with pigs inoculated with virus 42 days previously resulted in transmission of virus to 3 of 3 control pigs.
Postweaning multisystemic wasting syndrome (PMWS) is an emerging disease of swine first identified in 1991 in high-health swine herds in western Canada. 1, 13 Manifestations of PMWS include weight loss, respiratory distress, rough hair coat, pallor, diarrhea, jaundice, and death. 17, 18 Lymphadenopathy, gastric ulceration, hepatopathy, nephritis, and pneumonia are gross lesions associated with PMWS. 13, 17, 21 Microscopic lesions include cell depletion in lymphoid follicles, granulomatous inflammation of lymphoid tissues, homogenous, spherical, and basophilic cytoplasmic inclusion bodies of various sizes in histiocytic cells in lymphoid follicles, bronchointerstitial pneumonia, and lymphogranulomatous inflammation of the liver, kidney, and heart. 4, 13, 21, 28, 33 Small virus-like particles have been observed in and isolated from tissues from swine that had PMWS. 4, 13, 21 Those virus-like particles lack a lipid envelope and have an icosahedral capsid about 17 nm in diameter. Morphologically, the virus-like particles associated with PMWS resemble porcine circovirus (PCV), a known contaminant of the PK-15 cell line. 36, 37, 40 Analysis of the DNA nucleic acid sequence from the virus-like particles revealed high similarity with the DNA of the PCV from PK-15 cells. 15, [26] [27] [28] Although related genetically, the PCV associated with PMWS and the PCV in PK-15 cells differ sufficiently in nucleic acid sequence to allow classification as separate viral genotypes. The PCV in PK-15 cells appears representative of genotype 1 PCV (PVC1), and the recently identified PCV associated with PMWS appears representative of genotype 2 PCV (PCV2). 27 This classification has support from monoclonal and polyclonal antibody binding assays, which show that PCV1 and PCV2 are antigenically similar, but the viral genotypes can be segregated by serologic tests. 4, 13, 27 In previous studies, experimental inoculation of swine 1 day to 9 months of age with PCV1 did not induce signs of disease, and no overt gross or microscopic lesions were detected. 3, 38 Viral antigen was detected in numerous tissues, most often in lung and lymphoid tissue from pigs euthanized 3-11 days postinoculation (PI). 3 Virus was isolated from nasal swab specimens obtained during the first week PI and from fecal samples obtained on days 13 and 14 PI. 38 Gnotobiotic pigs 1 or 3 days of age, colostrum-deprived pigs 1-2 days of age, and conventional pigs 8 weeks of age have been inoculated with PCV2. 2, 6, 14, 20, 22 Mild to moderate disease was manifested by depression, low-grade fever, and reduced rate of weight gain, 2, 6 and severe disease noted in 1 pig resulted in loss of body weight. 2, 20 The primary macroscopic lesion was lymphadenopathy, but edema of the colonic mesentery and interstitial pulmonary edema was seen in 1 pig. 2, 14, 20 Microscopic lesions primarily were mild to moderate; histiocytic infiltration in lymph nodes was the most prominent lesion. 2, 6, 20, 22 Simultaneous inoculation of gnotobiotic or colostrum-deprived pigs with PCV2 and porcine parvovirus (PPV) has induced severe clinical disease and microscopic lesions consistent with those described in pigs from outbreaks of PMWS. 2, 14, 20, 22 In the current study, cesarean-derived, colostrumdeprived pigs 20 or 25 days of age were inoculated with the fourth cell culture passage of PCV2 strain 688 (PCV2/688). One purpose was to reproduce clinical signs of disease and the gross and microscopic lesions associated with PMWS. A second purpose was to determine clinical specimens and tissues from which virus could be isolated or in which viral DNA could be detected and to acquire preliminary information of duration of viral persistence in pigs.
Materials and methods
Animals. Mixed-breed cesarean-derived, colostrum-deprived pigs were obtained from date-mated sows. The pigs were housed individually in environmentally controlled isolation facilities and fed commercially available milk replacer until 10 days of age. On day 10 after birth, the pigs were allotted into 4 groups containing 15 (group A), 7 (group B), 8 (group C), or 5 (group D) pigs. Each group included pigs from 2 litters, and grouping was done by personnel that did not participate in the experiment. The groups of pigs were placed in separate biocontainment rooms on elevated decks with supplemental heat provided by heating pads and heat lamps. From days 10 to 17 after birth, the pigs were weaned gradually to a commercially available starter ration containing 21% protein. Rectal body temperature was recorded daily for each pig. Antibiotics were administered to pigs that had a body temperature of Ͼ40 C, hyperpnea, or diarrhea. All groups of pigs were treated similarly.
Cells and virus. A PCV-free clone of the PK-15 cell line was used for propagation, titration, and isolation of PCV2. The MARC-145 cell line was used for propagation and isolation of porcine reproductive and respiratory syndrome virus (PRRSV). The PT-1 clone a of the ST cell line was used for propagation and isolation of PPV. The PK-15 cell line (CCL 33) that is contaminated with PCV1 was obtained from the American Type Culture Collection and used for propagation of PCV1. Bovine turbinate cells were used for propagation and isolation of bovine viral diarrhea virus (BVDV). All cell cultures were grown in McCoy 5A medium containing 0.5 mg/ml kanamycin sulfate and supplemented to 6% with fetal bovine serum that tested free of BVDV and of antibody against BVDV. 7, 8 The PCV2 used here was isolated from a field outbreak of PMWS that occurred in Manitoba, Canada. That original viral isolate was contaminated with PPV. To obtain PCV2 free of PPV, the original viral isolate was passaged by inoculation into pigs. At 39 days PI, PCV2 was isolated from serum obtained from an inoculated pig that had detectable concentrations of antibody in serum against PPV for the previous 14 days. The virus was designated PCV2/688, and the fourth cell culture passage was used in the current study. The NADC-9 strain of PRRSV b and a field isolate of PPV b were used to test serum for antibody against those viruses. The Singer strain of type 1 BVDV and the 125C strain of type 2 BVDV were used to test for antibody against BVDV.
Viral inoculation, clinical specimens, and body weight. At 20 days of age, the 15 pigs in group A were inoculated with 3 ml of medium containing approximately 10,000 cell culture infective doses of PCV2/688. One milliliter of inoculum was injected into each nostril, and the remaining 1 ml of inoculum was injected into the subcutaneous tissue behind the right ear. At 25 days of age, the 8 pigs in group C were similarly inoculated with PCV2/688. At 20 or 25 days of age, the 7 pigs in group B and the 5 pigs in group D were inoculated with 3 ml of medium harvested from PCV-free PK-15 cells. Before inoculation, each pig was weighed and a sample of blood was obtained for hematology, viral isolation, and serology. Rectal, tonsil, and nasal swab specimens also were obtained for viral isolation. The swabs were placed in tubes containing 1 ml of medium for transport to the laboratory. At 2-6-day intervals through day 28 PI, samples of blood and rectal, tonsil, and nasal swab specimens were obtained from several pigs in each group. After day 28 PI, viral isolation was attempted periodically from serum or buffy coat cells. Body weight was recorded each time clinical specimens were obtained through day 28 PI. At postmortem, urine was aspirated from the bladder for viral isolation. Also, lung lavage was done to obtain alveolar macrophages for viral isolation.
Contact exposure. At 42 days PI, 3 pigs from group C inoculated with PCV2/688 at 25 days of age were moved to a clean biocontainment room and placed in contact with 3 control pigs of like age from group D that had been sham inoculated with medium from PCV-free PK-15 cells. The pigs were observed daily for signs of disease. A sample of serum was obtained at weekly intervals from the control pigs to monitor for antibody production against PCV2. Buffy coat cells and serum from those pigs were used for viral isolation; however, other clinical specimens were not obtained and body weight was not recorded.
Viral isolation. Viral isolation was done by inoculation of PCV-free PK-15 cells grown in 24-well tissue culture plates with 0.1 ml of serum, urine, or filtered lung lavage fluids. A like volume of filtered rectal, tonsil, or nasal swab specimens was used for viral isolation. Cells in lung lavage fluid were pelleted by centrifugation for 15 min at 1,000 ϫ g. Buffy coat cells were aspirated off packed blood cells in tubes containing ethylenediaminetetraacetic acid (EDTA) after centrifugation for 10 min at 1,500 ϫ g. Buffy coat cells and lung lavage cell pellets were suspended in 1 ml of medium and frozen at Ϫ80 C. Viral isolation was done by inoculation of 0.1 ml of thawed material onto PCV-free PK-15 cells grown in 24-well tissue culture plates. All viral isolation plates were incubated for 8 days at 39 C in a humidified atmosphere containing 5% CO 2 and then were frozen at Ϫ20 C. Isolation of PRRSV was attempted from lung lavage fluids and cell pellets using MARC-145 cells grown in 24-well tissue culture plates. The MARC-145 cells were observed for cytopathic effect for 8 days. As an internal control for cross-contamination of wells in the 24-well plates, specimens from the sham-inoculated control pigs were included in each plate and mixed among wells containing specimens from infected pigs.
Viral isolation also was attempted from tonsil, distal ileum, spleen, liver, kidney, mesenteric lymph node, thymus, lung, midbrain, cerebellum, and cerebrum obtained from some pigs postmortem. Approximately 1 g of tissue was minced with a razor blade and ground in a Tenbroeck tissue grinder containing 7 ml of medium. The resulting suspension was clarified by centrifugation at 1,000 ϫ g for 15 min. The clarified fluid was passaged through a 0.22-m filter and inoculated onto PCV-free PK-15 cells seeded into a 25-cm 2 flask. After 5 days of incubation at 39 C, cells and medium were removed from the 25-cm 2 flask and placed into a 75cm 2 flask containing 15 ml of fresh medium. After 48 hr, the medium in the 75-cm 2 flasks was removed and replaced with 8 ml of Hanks balanced salt solution containing 300 mM Dglucosamine. After incubation at room temperature for 30 min, the solution containing D-glucosamine. was replaced with 20 ml of fresh medium, and the flasks were incubated at 39 C for 72 hr. The flasks were then frozen and stored at Ϫ20 C until tested for viral DNA.
Hematology and serology. White blood cell count, red blood cell (RBC) count, hematocrit, and platelet count were obtained using an automated cell counter. c A differential white blood cell count was obtained by hand. Sera were tested for antibody against PCV2/688, PCV1, PPV, and PRRSV in 96-well microtitration plates with minor modifications of a described procedure. 7, 8 The PK-15 cells persistently infected with PCV1 or PCV2/688 were seeded into wells of a microtitration plate and grown at 39 C in a humidified atmosphere containing 5% CO 2 . After 48 hr, the medium was removed and 50 l of Hanks balanced salt solution containing 300 mM D-glucosamine was added to each well. After a 30-min incubation at room temperature, that solution was replaced with 100 l of fresh medium, and the plates were incubated at 39 C for 48 hr. The plates were then prepared for immunoperoxidase staining of viral antigen as previously described. 8 The initial dilution of serum was 1:8 in binding buffer. Serial 5-fold dilutions of serum in binding buffer were made in wells of the microtitration plate. Recombinant protein G-peroxidase d conjugate was used to label antibody bound to viral antigen. Minor modifications of the procedure were made to test for antibody against PRRSV, PPV, or BVDV. For PRRSV, 96-well microtitration plates were seeded with MARC-145 cells and incubated at 37 C until a cell monolayer was formed. The cell monolayer was inoculated with the NADC-9 strain of PRRSV and incubated for 20 hr before staining. For PPV, PT-1 cells were mixed with PPV and seeded into 96-well microtitration plates. The plates were stained after incubation for 20 hr. For BVDV, bovine turbinate (BT) cells were seeded into 96-well microtitration plates and incubated at 37 C until a cell monolayer had formed. The BT cells were inoculated with the Singer strain of type 1 BVDV or the 125C strain of type 2 BVDV and incubated at 37 C for 18 hr before the plates were stained.
Postmortem examination. Pigs inoculated with PCV2/688 were euthanized for postmortem examination on PI days 20 (n ϭ 3), 21 (n ϭ 2), 22 (n ϭ 2), 23 (n ϭ 1), 24 (n ϭ 2), 27 (n ϭ 1), 28 (n ϭ 3), 35 (n ϭ 5), 52 (n ϭ 2), and 125 (n ϭ 2). Pigs sham inoculated with medium were euthanized for postmortem examination on PI days 20 (n ϭ 1), 24 (n ϭ 2), and 28 (n ϭ 1). Gross lesions were noted, and the following tissues were harvested for microscopic examination: inguinal lymph node, internal iliac lymph node, testicle, ovary, uterus, urinary bladder, kidney, adrenal gland, spleen, pancreas, liver, stomach, duodenum, jejunum, distal ileum, cecum, ileocecal valve, colon, rectum, mesenteric lymph node, lung, bronchial lymph node, heart, thymus, thyroid, trachea, esophagus, superficial cervical lymph node, mandibular lymph node, mandibular salivary gland, tonsil, cerebellum, cerebrum, midbrain, pituitary gland, and bone marrow. Tissues were fixed in 10% neutral buffered formalin for 24-48 hr, trimmed, and placed in 70% ethanol for routine processing and paraffin embedment. Tissues obtained at postmortem for detection of viral DNA using the polymerase chain reaction technique (PCR) included kidney, spleen, liver, pancreas, adrenal gland, mesenteric lymph node, distal ileum, lung, bronchial lymph node, heart, thymus, tonsil, bone marrow, cerebrum, cerebellum, and midbrain. The tissues were stored frozen at Ϫ20 C until processed for PCR. The three contact exposure pigs were euthanized for postmortem examination on day 43 after initial contact with convalescent pigs. Tissues obtained from those pigs for microscopic examination included liver, kidney, distal ileum, lung, heart, thymus, tonsil, mesenteric lymph node, and inguinal lymph node.
Polymerase chain reaction. Aligned nucleic acid sequences of PCV1 and PCV2 were used to design PCR primers that amplified a 580-bp fragment of DNA from either PCV1 or PCV2. The sequences of those primers were 286, 5Ј-CCCGCTGCTACATCGAGAAA-3Ј; 865, 5Ј-TCTACA-GCTGGGACAGCAGTTG-3Ј (base positions from sequence of PCV2). The PCR reaction mixture contained 200 M dNTP, 1.5 mM MgCl 2 , 30 pM each primer, 1ϫ Taq buffer, e and 0.75 units Taq polymerase e in a final volume of 27 l. Reaction conditions were 95 C for 10 min (1 cycle) followed by 35 cycles of 95 C for 20 sec, 55 C for 30 sec, and 72 C for 40 sec and then a final cycle at 72 C for 5 min. To confirm amplified DNA was from PCV2, a second PCR reaction was done on select samples to produce an amplicon of 256 bp. The PCR primers used were 610, 5Ј-TTGCA-GACCCGGAAACCAC-3Ј; 865, 5Ј-TCTACAGCTGGGA-CAGCAGTTG-3Ј (base positions from sequence of PCV2). To detect possible contamination with PCV1, DNA harvested from select samples of clinical specimens or tissues was amplified with PCR primers 174, 5Ј-TGTTTGCGGAGAG-GAAGGTTTGG-3Ј (base positions from sequence of PCV1) and 865, 5Ј-TCTACAGCTGGGACAGCAGTTG-3Ј. This last set of primers produced a 692-bp fragment of DNA from PCV1.
Isolation of PCV2 from clinical specimens was detected using the same primer sets to amplify viral DNA from frozen and thawed 24-well tissue culture plates. Medium plus cell debris (180 l) was mixed with 20 l lysis buffer (100 mM Tris-HCl, pH 8.0, 10 mM EDTA, pH 8.0, 0.5% Triton X-100) and incubated at 100 C for 10 min. After a 5-min incubation on ice, the mixture was centrifuged for 3 min at 1,200 ϫ g. Clarified supernatant (3 l) was removed and added to 27 l of PCR reaction mixture for amplification of viral DNA. To detect viral DNA in tissues, approximately 50 mg of tissue was minced with a razor blade and placed in 450 l of digestion solution (10 mM Tris-HCl, pH 8.3, 50 mM KCl, 0.5% polyoxyethylenesorbitan monolaurate, 90 g proteinase K). The digestion mixture was incubated overnight with agitation at 37 C. The digested material was vortexed briefly, centrifuged at 1,200 ϫ g for 1 min, incubated in boiling water for 10 min, chilled on ice for 5 min, and centrifuged at 18,000 ϫ g for 3 min. Clarified supernatant (3 l) was removed and added to 27 l of PCR reaction mixture for amplification of viral DNA.
In situ hybridization. A 580-bp fragment of DNA from PCV1 was amplified by PCR using the first set of primers. The amplicon was blunt-end cloned into a plasmid vector containing T7 and Sp6 promoters using a kit. f Using a second kit, g the cloned DNA was transcribed with either Sp6 or T7 RNA polymerase in the presence of digoxigenin-labeled UTP. This produced sense and antisense digoxigeninlabeled riboprobes. Sections of formalin-fixed tissue were deparaffinized, treated with proteinase K, and prepared for in situ hybridization as previously described. 26, 32, 34 The hybridization buffer was 50% deionized formamide, 3ϫ standard saline citrate (SSC) solution, 1ϫ Denhardt solution, 0.2 mg/ml yeast tRNA, 50 mM sodium phosphate (pH 7.4), and 10% (w/v) dextran sulfate. The digoxigenin-labeled riboprobes were added to the hybridization buffer and heated to 80 C for 2 min, cooled on ice, and applied to tissue sections for overnight incubation at 50 C. The tissue sections were washed twice for 5 min in 2ϫ SSC at room temperature, flooded with a solution of 10 mM Tris-HCl and 0.5 M NaCl (pH 8.0) containing 20 g/ml ribonuclease A, h and incubated for 30 min at 37 C in a humidified chamber. The tissue sections were washed with SSC solutions prewarmed to 50 C as follows: 2ϫ SSC for 5 min, 1ϫ SSC for 5 min, and 0.5ϫ SSC for 1 hr. A final wash was done with 0.5ϫ SSC at room temperature for 5 min. Kits were used to block nonspecific reactions i and for enzyme-linked immunoassay and enzyme-catalyzed color reactions. j
Results
Clinical signs and rate of weight gain. A body temperature of Ͼ40 C (fever) was recorded rarely from day 0 to day 28 PI in the 12 sham-inoculated control pigs in groups B and D. During that period, this elevated temperature was never recorded on more than 2 successive days nor on more than 3 days total for any pig. Other signs of disease were not observed in the control pigs. For 12 of 23 pigs from groups A and C inoculated with PCV2/688, fever was recorded intermittently between days 12 and 20 PI; however, fever never was recorded on more than 2 successive days nor on more than 4 days total. Palpable enlargement of the inguinal, prefemoral, and popliteal lymph nodes was noted in 9 of those 12 pigs from about day 16 to day 22 PI. Serum from 1 of those 12 pigs appeared icteric at postmortem on day 29 PI. A persistent fever occurred in 11 of 23 pigs from groups A and C inoculated with PCV2/688. In those pigs, fever was recorded on 7-17 successive days, beginning on about day 12 PI. Those pigs became depressed, and most were euthanized for humane purposes between days 20 and 28 PI. During the period of persistent fever, the temperature fluctuated from 40.1 C to 41.4 C. The hair on those pigs became erect, and many pigs appeared to shiver. Palpable enlargement of inguinal, prefemoral, and popliteal lymph nodes was noted in all affected pigs at about day 16 PI and persisted for 4-7 days. The skin of 6 of the 11 pigs became yellowish between days 21 and 26 PI. During that time, the serum from those 6 pigs had a distinct yellow to yellow-brown color. Hyperpnea was observed in 2 pigs with persistent fever, but diarrhea was not observed. The control pigs placed in contact with infected pigs did not develop a fever and did not show clinical signs of disease.
The average daily rate of weight gain between days 14 and 28 PI was lower in groups of pigs exposed to PCV2/688 than in groups of control pigs of similar ages ( Table 1 ). During that time, the amount of fecal material in pens of pigs inoculated with virus was noticeably less than that in pens of control pigs. Three † Antibodies against PCV1 and PCV2 were not detected on or before day 12 PI. of 11 pigs that had persistent fever lost body weight in the last 2-3 days of life. Only 2 pigs that had persistent fever survived to day 28 PI, and rate of weight gain for those pigs was about half that of control pigs.
Viral isolation from clinical specimens. PCV1, PCV2, PPV, BVDV, and PRRSV were not isolated from clinical specimens obtained from control pigs. Isolation of PCV2, as detected by PCR, was infrequent from nasal, rectal, or tonsil swab specimens obtained from pigs inoculated with PCV2/688. From those specimens, virus was isolated between only days 12 and 19 PI. During that period, virus was isolated from 6 of 28 rectal swabs obtained from 5 of 14 pigs. Virus also was isolated from 3 of 28 tonsil swabs and 1 of 28 nasal swabs obtained from the same 14 pigs. Viral isolation from rectal, tonsil, or nasal swabs was not detected before day 12 or after day 19 PI. Viral isolation from urine was detected from only 1 pig at 28 days PI. Between days 20 and 28 PI, virus was isolated from lung lavage fluid from 5 of 14 pigs and from the lung lavage cell pellet from 11 of 14 pigs. Virus was first isolated from buffy coat or serum at 12 days PI. Between days 12 and 35 PI, virus was isolated from 49 of 67 samples of buffy coat cells obtained from 23 pigs. Between days 12 and 28 PI, virus was isolated from 20 of 60 samples of serum obtained from 23 pigs. Virus was not isolated from serum after day 28 PI.
Hematology and serology. Most pigs inoculated with virus had normal hematologic profiles through day 28 PI, regardless of severity of clinical disease. Four pigs that showed signs of disease developed neutropenia (Ͻ1,000 neutrophils/mm 3 ), lymphopenia (Ͻ1,000 lymphocytes/mm 3 ), or anemia (Ͻ4 ϫ 10 6 RBC/mm 3 , hematocrit Ͻ21 %). Those hematologic abnormalities were seen after day 19 PI.
No antibodies against BVDV, PPV, or PRRSV were detected in serum obtained from any pig. Antibody against PCV2/688 was detected in serum between days 15 and 19 PI in all pigs of group C that were inoculated with virus at 25 days of age. Antibody against PCV2/688 was first detected in serum on day 19 PI in pigs of group A that were inoculated with virus at 20 days of age. However, 4 of 15 pigs in group A failed to produce detectable concentrations of antibody in serum before death at days 20-24 PI. The titer of antibody against PCV2/688 in serum increased steadily for about 3 weeks after first detection. Antibody in serum that cross-reacted with PCV1 was not detected until several days after detection of antibody against PCV2/ 688. The titer in serum of antibody against PCV1 always was less than the titer of antibody against PCV2/ 688 ( Table 2) .
Postmortem examination. Gross or microscopic lesions were not observed in control pigs. Gross lesions were most prominent in pigs that developed persistent fever after inoculation with PCV2/688. Moderate to marked lymphadenopathy of inguinal, prefemoral, internal iliac, mesenteric, gastric, bronchial, and/or mandibular lymph nodes was a common gross lesion observed from 20 to 35 days PI. Other gross lesions observed during that period included generalized icterus of skin, subcutis, adipose tissue, sclera of the eye, intestines, and liver. Ascites was common in pigs that were icteric. Lesions in the kidney included scattered white foci on the cortical surface, often accompanied by pitting of the surface, and occasional hemorrhage in the medulla. After day 35 PI, scattered white foci and pitting on the surface of the kidney was the most frequent gross lesion. Scattered white foci and pitting on the surface of the kidney was seen in 2 of 3 control pigs euthanized 43 days after being placed in contact with convalescent pigs that had been inoculated with PCV2/688. Microscopic lesions also were most prominent in pigs that developed persistent fever. Those lesions included mild to extensive lymphocyte depletion of lymphoid follicles in spleen, tonsil, lymph nodes, and intestines (Fig. 1) . The lymphoid follicles were infiltrated with large macrophage-like cells, some of which contained 1 to numerous round basophilic cytoplasmic inclusion bodies of various sizes (Fig. 2) . In the liver, lesions ranged from single cell necrosis of hepatocytes to massive hepatic necrosis. Interlobular fibroplasia with periportal lymphohistiocytic cell infiltrates was a common lesion. Pancreatic necrosis with infiltration by lymphocytes and neutrophils was seen in some pigs. Lymphocyte infiltration of the renal cortical interstitium was common in pigs euthanized after day 35 PI and was seen in 2 of 3 pigs euthanized on day 43 after contact exposure (Fig. 3) . Interstitial pneumonia was mild and multifocal in pigs euthanized between 20 and 28 days PI and rare in pigs euthanized after day 28 PI. Lymphocytic myocarditis was mild and rare before day 35 PI but became a more common lesion after day 35 PI.
Detection of viral DNA in tissues. Using PCR amplification, DNA from PCV2 was detected in all tissue obtained from pigs inoculated with virus ( Table 3) . Specificity of the PCR reaction was confirmed on select samples of tissue using a second round of PCR that specifically amplified DNA of PCV2 (Fig. 4) . Obvious difference in number of tissues that were positive for viral DNA using PCR was not detected between pigs that exhibited mild and those that exibited severe signs or lesions of PMWS. Viral DNA was detected most frequently in brain, lung, and lymphoid tissue during the acute and early convalescent phases of disease (Table 3 ). Viral DNA was detected in some tissues up to 125 days PI (Table 3) . To confirm presence of infectious virus, viral isolation was done on homogenates of tissues obtained from some pigs euthanized between days 20 and 28 PI and from all pigs euthanized at 52 or 125 days PI. Virus was isolated from all tissues in which viral DNA was detected using PCR. In addition, virus was isolated occasionally from tissues in which viral DNA was not detected using PCR. Viral isolation was confirmed by immunoperoxidase staining of PK-15 cells inoculated with tissue homogenates. Viral DNA was not detected using PCR in tissues obtained from control pigs euthanized between 20 and 28 days after sham inoculation with medium.
In situ hybridization. To confirm presence of viral DNA in tissues in which lesions were observed, in situ hybridization was done using riboprobes that reacted with the encapsidated or complementary strands of viral DNA. The probe for encapsidated DNA reacted with histiocytic cells in lymphoid follicles depleted of lymphocytes ( Fig. 5 ), alveolar macrophages of the lung, Kupffer cells and hepatocytes in the liver, macrophage-like cells in the lamina propria of intestinal villi, cells in the perivascular connective tissue in the pancreas, cells in the medulla of the thymus, and various cell types of the bone marrow. The probe for the complementary viral DNA reacted with similar cell types but with appreciably fewer cells. Brain, heart, kidney, ovary, testes, uterus, endocrine glands, and salivary glands contained a few scattered cells that contained viral DNA. In general, the number of cells con- taining viral DNA was greater in pigs that had severe lesions, and the number of cells that contained viral DNA decreased with time after day 25 PI. Cells that reacted with either riboprobe were not found in like tissues from control pigs.
Discussion
Most of the clinical signs and gross and microscopic lesions associated with PMWS were observed in pigs experimentally inoculated with PCV2/688. At about 2 weeks PI, 11 of 23 pigs developed persistent fever that was not responsive to antibiotic therapy. The persistent fever was prognostic in that severe disease was evident after 5-7 days of fever. Pigs that did not develop a persistent fever recovered from the experimental infection, had minimal signs of disease, and had mild to moderate gross or microscopic lesions on postmortem examination. All pigs that developed persistent fever had palpably enlarged inguinal, prefemoral, and popliteal lymph nodes by days 16-18 PI. Depression and icterus were common in those pigs from day 20 to day 27 PI. Humane treatment necessitated euthanasia of pigs before death from disease; however, at least 50% of pigs that developed persistent fever (6 of 11 pigs) probably would have died from PMWS. The estimated high mortality rate for pigs showing signs of severe disease in the current study is consistent with findings from field outbreaks of PMWS, in which mortality rates average about 80% for pigs showing disease. 17 Lesions previously associated with PMWS that were seen in the current study included lymphadenopathy, icteric tissues and ascitic fluid, hepatic cell necrosis, depletion of small lymphoid cells in lymphoid follicles, multifocal granulomatous inflammation of liver, kidney, and lymphoid tissue, and cytoplasmic inclusion bodies in histiocytic cells in depleted lymphoid follicles. 4, 11, 13, [19] [20] [21] [22] 25, 28, 30, 33 In contrast to reports from field outbreaks of PMWS, 4, 17, 19, 21, 28, 30, 33 diarrhea and skin pallor were not observed in the current study. Hyperpnea was observed in pigs that had fever, but respiratory distress was not observed. The interstitial pneumonia seen on microscopic examination of lung was multifocal and mild, as compared with extensive bronchointerstitial pneumonia seen frequently in the field. Multinucleate syncytial cells often found in lung and lymphoid tissue from pigs with naturally occurring PMWS were rarely observed in the current study. 10, 11, 13, 19, 21, 25, 33 In previous reports, experimental inoculation of pigs with PCV1 or PCV2 either failed to induce disease or lesions or induced clinical disease and lesions that primarily varied from mild to moderate in the majority of pigs and were moderate to severe in 1 pig. [2] [3] [4] 6, 20, 22, 38 Those findings are consistent with the mild disease and mild to moderate lesions seen in the present study in pigs that had infrequent fever after inoculation with PCV2/688. The reduced rate of weight gain observed in pigs inoculated with PCV2/688 was reported in conventional pigs after intranasal inoculation with a homogenate of tissues obtained from a field outbreak of PMWS. 6 Severe disease and extensive lesions consistent with PMWS have been reported after simultaneous infection of pigs with PCV2 and PPV. 2, 14, 20, 22 Mixed infections of PCV2 with PCV1, PPV, PRRSV, pseudorabies virus, and Chlamydia occur during field outbreaks of PMWS. 9, 12, 13, 19, 23, 24, 31, 32 The contribution of infectious agents other than PCV2 to PMWS is unknown, but pathogenic synergism between infectious agents may be a factor in the severity of PMWS. During this study, the stock PCV2 used to inoculate pigs was tested for adventitious agents, but none were found. Serum obtained from pigs was tested for antibody against PPV, PRRSV, and BVDV, which were considered likely contaminants of the stock virus. No antibodies against those viruses were detected in serum obtained through 125 days PI.
The in vitro growth characteristics of PCV in cell culture makes viral isolation time consuming and detection of isolated virus difficult. 39 These difficulties probably have prompted numerous reports in which PCR was the primary method used for detection of PCV in tissues or cell cultures. 11, [14] [15] [16] 23, 24, 28, 29, 31 Therefore, the utility of clinical specimens and tissues for viral isolation or for detection of viral DNA was evaluated in the present study. The duration of time after initial infection with PCV2 that viral DNA could be detected using PCR also was evaluated.
Viral DNA was detected after inoculation of cell cultures with each type of clinical specimen tested, and viral DNA was detected in each type of tissues tested. The frequency of detection of viral DNA and length of time after date of infection that viral DNA was detected differed with the clinical specimen or tissue. Of the clinical specimens obtained ante mortem, PCV2 was detected most frequently after viral isolation from buffy coat cells. Virus was detected in multiple samples of buffy coat cells obtained from each pig over an extended period of time. Detection of virus from buffy coat cells was successful Ն2 weeks after detection of antibody against PCV2 in serum and up to 5 weeks after the date of experimental infection. Detection of virus in serum was accomplished readily beginning about 2 weeks PI. Appearance of antibody in serum correlated with loss of cell culture infective vi-rus in serum. Although others have had success with isolation of PCV from nasal swab specimens and fecal samples, 38 in the current study virus was detected in nasal, rectal, and tonsil swab specimens only infrequently between 12 and 19 days PI. The methods used in the current study for viral isolation and for PCR may not have allowed efficient detection of virus in those specimens. The rapid seroconversion of the contact exposure pigs in the current study certainly suggests that excretions and/or secretions from the body contain infectious virus.
The tissues in which viral DNA was detected most frequently using PCR were brain, lung, and lymphoid tissue. Viral DNA was detected regularly in those tissues from day 20 PI through day 35 PI and infrequently through day 125 PI. In many studies that have used PCR or in situ hybridization, 6, 10, 12, 15, 19, [23] [24] [25] [28] [29] [30] [31] [32] [33] lung and lymphoid tissue have been reported to contain viral DNA. Viral antigen has been reported in brain from a pig experimentally coinfected with PCV2 and PPV, but PCV2 was not detected in brain tissue from pigs experimentally infected with PCV2 alone. 2 The presence of viral DNA in tissue was confirmed using in situ hybridization. Numerous cells containing viral DNA were found in lymphoid tissue, liver, and lung of pigs euthanized between days 20 and 28 PI. Similar to previous reports on PMWS, 4, 6, 9, 10, 25, 28, 32, 33, 35 in the current study the cell types most frequently found to contain viral DNA were of monocyte/macrophage lineage. Although brain tissue frequently was positive for PCV2 using PCR, few cells in the brain contained viral DNA when examined using in situ hybridization. Those cells usually were located in the perivascular connective tissue adjacent to small blood vessels in the brain. The conditions used for in situ hybridization, the sensitivity of the procedure, or the choice of probe might account for limited detection of viral DNA in brain. The distribution of cells and cell types that contained viral DNA in pancreas, kidney, intestine, and bone marrow were consistent with that in previous reports. 4, 6, 9, 10, 25, 28, 32, 33 In the heart, scattered myocytes and cells in the perivascular connective tissue adjacent to small blood vessels contained viral DNA. That finding is consistent with a report of detection of PCV2 in the heart of aborted porcine fetuses. 41 Viral DNA was detected using PCR in tissue obtained postmortem on days 52 and 125 PI. Attempts at isolation of infective virus from those tissues were successful. The extended duration after experimental inoculation with PCV2 that infective virus was isolated from tissue indicates that a persistent infection was established. This finding has importance for disease control strategies because it suggests that apparently healthy adult pigs may be carriers of PCV2. Contact transmission of virus from older to younger pigs also may be an important means for spread of PCV2. At 42 days PI, pigs in this study apparently still shed infectious virus; seronegative control pigs all produced antibody within 3 weeks of contact exposure.
The serology performed in the present study confirmed results of previous studies in which PCV1 and PCV2 were found to be antigenically similar but could be differentiated by serologic tests. 4, 5, 13 In the current study, the titer of antibody against PCV2 always was much greater than the titer of antibody against PCV1. Thus, differential serologic tests could be used to identify the genotype of PCV in infected herds.
